Behind the Headlines – Vaccine ‘could stop diabetes’
Although the study described above contributes to the evidence suggesting that enterovirus could be one of these triggering viruses, its results are not conclusive. More research will be needed before it becomes clear whether a vaccine targeting enterovirus can tackle type 1 diabetes (Behind the Headlines, NHSChoices)
Napping increases risk of diabetes
Taking regular lunchtime siestas could increase the risk of developing Type 2 diabetes, according to the findings of a research study being presented this week at Diabetes UK’s Annual Professional Conference in Glasgow (Diabetes UK)
Feasibility of using videoconferencing to provide diabetes education: a pilot study
The results suggest that providing nutritional therapy via videoconferencing may be useful in assisting patients to manage their conditions (Journal of Telemedicine and Telecare)
The inhibitory association of recent type 2 diabetes risk loci on insulin secretion is modulated by insulin sensitivity
The negative effects of the risk alleles on ß-cell function appear additive in subjects with low insulin sensitivity, but not in subjects with high insulin sensitivity. Effective compensatory mechanisms may exist in subjects with high insulin sensitivity that limit these genes’ impact (Journal of Clinical Endocrinology & Metabolism)
MannKind Biopharmaceuticalsto Buy Pfizer Inc. (PFE)’s Insulin Plant in Germany for $33 Million
MannKind Corporation announced that it has entered into agreements with Pfizer Inc. to purchase Pfizer’s insulin facility at Industriepark Hoechst, Frankfurt am Main, Germany and assets related to the production of bulk insulin, including the relevant real property rights, the production equipment, a quantity of bulk insulin and a license to manufacture bulk insulin for use in pulmonary delivery (BioSpace)
Surface Logix Raises $20 Million in Financing and Starts Phase 2b Clinical Trial of SLx-4090 in Dyslipidemia and Diabetes
SLx-4090 has potential not only in dyslipidemia but also in obesity and diabetes as a result of the compound’s ability to restrict energy absorption by reducing the uptake of triglycerides (BioSpace)
Continuous Quality Improvement in Diabetes Services
Findings from DiabetesE – Fourth National Report. 104-page PDF (NHS Diabetes)
Doctors deliver fresh warning over new QOF diabetes targets
Tighter blood glucose control targets for Type 2 diabetes in the QOF are not evidence-based and may do more harm than good, two doctors are warning (Pulse)
Diabetes drugs given ‘too soon’
One in three people with type 2 diabetes are given medication too soon, instead of being urged to eat better and do more exercise, a study suggests (BBC)
Diabetic retinopathy highly prevalent in UK South-Asian population
A primary-care based study has shown that Type 2 diabetes patients of South–Asian ethnicity living in the UK have a significantly higher prevalence of diabetic retinopathy than their White–European counterparts (Medwire News)
Basal-bolus therapy with insulin detemir using the 303 algorithm in the US PREDICTIVE 303 trial
Adjustments of a once-daily detemir dose by patients using the 303 Algorithm in a basalbolus setting is equally effective in improving glycemic control in patients with type 2 diabetes compared with physician-directed basal dose adjustment (PubMed)
FDA says Takeda’s alogliptin data is not “sufficient”
Takeda Pharmaceutical Co faces a delay in getting alogliptin to market after US regulators said that they need more data to evaluate the Japanese drugmaker’s experimental type 2 diabetes drug (PharmaTimes)
Color-Changing Tattoos Could Be the Next BG Level Detector
Scientists at a Cambridge, Massachusetts, laboratory who set out to develop a tattoo for tracking heart health may now be on track for developing a tattoo for people with diabetes that changes color as blood glucose levels rise and fall (Diabetes Health)
DAFNE (Dose Adjustment For Normal Eating)
A skills-based structured education programme in intensive insulin therapy (IIT) delivered by specially trained diabetes specialist nurses and dieticians (NHS)
Data from the 2006-07 QOF for diabetes care
An update of the latest data from the Quality and Outcomes framework for Diabetes at the PCT level within Yorkshire and Humber. PDF (YHPHO)
Virus ‘triggers child diabetes’
A common virus may be the trigger for the development of many cases of diabetes, particularly in children, UK researchers have reported (BBC)
New Tel Aviv University research links diabetes to cognitive deterioration
“Our results send an important message to the public,” says Dr. Cukierman-Yaffe. “We have shown conclusively that there is a relationship between diabetes and cognitive dysfunction. This should be known by diabetics and their doctors (EurekAlert)
Canada to host diabetes mega-congress
The International Diabetes Federation brings its World Diabetes Congress to Montreal in October, with over 15,000 people expected to attend (IDF)
American Diabetes Association Statement on the White House Health Reform Summit
The American Diabetes Association has offered a series of recommendations for comprehensive health reform to reduce the burden of diabetes (ADA)
Lazard sees Amylin’s exenatide as a blockbuster
Lazard Capital Markets analyst Matthew Osborne reaffirmed a “Buy” rating on Amylin Pharmaceuticals Inc. Monday, saying Byetta’s next-generation diabetes drug exenatide LAR will likely be a multibillion-dollar treatment if it is approved (CNBC)
Treatment satisfaction of diabetic patients: what are the contributing factors?
Treatment satisfaction is lower among diabetic patients who have a lower educational level, who are insulin treated or have a diabetic complication and is related to difficulties in taking medications and coming to follow-up visits (Family Practice)
Pioneering Diamyd(r) Study to Prevent Childhood Diabetes Approved
The Swedish Medical Products Agency has approved a study with the Diamyd(r) diabetes vaccine in children with high risk to develop type 1 diabetes (MarketWatch)
And Now We Are… “ePharma Consumers”
Manhattan Research, a highly respected pharmaceutical and healthcare market research firm, has invented a new buzz-term for consumers who use the Internet to research info on prescription drugs: “ePharma Consumers.” (Diabetes Mine)
Glycosmedia is also available as an App: